Ascochlorin suppresses TGF-β1-induced PAI-1 expression through the inhibition of phospho-EGFR in rat kidney fibroblast cells

[1]  Ji-Hak Jeong,et al.  Ascochlorin, an isoprenoid antibiotic, induces G1 arrest via downregulation of c-Myc in a p53-independent manner. , 2010, Biochemical and biophysical research communications.

[2]  Ji-Hak Jeong,et al.  p53-Independent Induction of G1 Arrest and p21WAF1/CIP1 Expression by Ascofuranone, an Isoprenoid Antibiotic, through Downregulation of c-Myc , 2010, Molecular Cancer Therapeutics.

[3]  T. Cheng,et al.  The linker region of Smad2 mediates TGF-beta-dependent ERK2-induced collagen synthesis. , 2009, Biochemical and biophysical research communications.

[4]  Young-Chae Chang,et al.  Suppression of PAI‐1 expression through inhibition of the EGFR‐mediated signaling cascade in rat kidney fibroblast by ascofuranone , 2009, Journal of cellular biochemistry.

[5]  Young-Chae Chang,et al.  Ascochlorin suppresses oxLDL‐induced MMP‐9 expression by inhibiting the MEK/ERK signaling pathway in human THP‐1 macrophages , 2007, Journal of cellular biochemistry.

[6]  J. Gaedeke,et al.  Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1. , 2005, Kidney international.

[7]  H. Ha,et al.  Plasminogen activator inhibitor‐1 and diabetic nephropathy , 2005, Nephrology.

[8]  K. Ohba,et al.  Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. , 2005, The Journal of urology.

[9]  Craig E. Higgins,et al.  Plasminogen activator inhibitor type‐1 gene expression and induced migration in TGF‐β1‐stimulated smooth muscle cells is pp60c‐src/MEK‐dependent , 2005, Journal of cellular physiology.

[10]  Young-Chae Chang,et al.  Ascochlorin Inhibits Matrix Metalloproteinase-9 Expression by Suppressing Activator Protein-1-mediated Gene Expression through the ERK1/2 Signaling Pathway , 2005, Journal of Biological Chemistry.

[11]  S. Belmadani,et al.  Involvement of Metalloproteinases 2/9 in Epidermal Growth Factor Receptor Transactivation in Pressure-Induced Myogenic Tone in Mouse Mesenteric Resistance Arteries , 2004, Circulation.

[12]  F. Verrecchia,et al.  TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression. , 2004, Cellular signalling.

[13]  Y. Kaneda,et al.  Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo , 2004, Gene Therapy.

[14]  J. Ling,et al.  Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. , 2004, Investigative ophthalmology & visual science.

[15]  Christopher J. Lyon,et al.  Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. , 2003, The American journal of medicine.

[16]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[17]  P. Higgins,et al.  Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene , 2002, Journal of Cell Science.

[18]  Katsunori Yoshida,et al.  Differential regulation of TGF‐β signal in hepatic stellate cells between acute and chronic rat liver injury , 2002, Hepatology.

[19]  P. Goldschmidt-Clermont,et al.  Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  E. Rondeau,et al.  Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. , 2000, Kidney international.

[21]  S. Hubchak,et al.  TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. , 1999, Kidney international.

[22]  E. Nishida,et al.  Involvement of the p38 Mitogen-activated Protein Kinase Pathway in Transforming Growth Factor-β-induced Gene Expression* , 1999, The Journal of Biological Chemistry.

[23]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[24]  J. Magae,et al.  Antitumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes. , 1988, The Journal of antibiotics.

[25]  M. Yamasaki,et al.  In vitro effects of an antitumor antibiotic, ascofuranone, on the murine immune system. , 1986, Cancer research.

[26]  G. Tamura,et al.  An Ascochlorin Derivative, AS-6, Reduces Insulin Resistance in the Genetically Obese Diabetic Mouse, db/db , 1985, Diabetes.

[27]  G. Tamura,et al.  Alteration of cholesterol metabolism by 4-0-methylascochlorin in rats , 1981, Lipids.

[28]  G. Tamura,et al.  Unusual concentration of urine and prevention of polydipsia by fungal prenylphenols in DOCA hypertensive rats. , 1981, European journal of pharmacology.

[29]  K. Ando,et al.  Hypolipidemic property of ascofuranone. , 1973, The Journal of antibiotics.

[30]  H. Sasaki,et al.  Isolation and structure of ascofuranone and ascofranol, antibiotics with hypolipidemic activity. , 1973, The Journal of antibiotics.

[31]  Ling Yu,et al.  Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. , 2006, Kidney international.

[32]  J. Fitzpatrick,et al.  Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. , 2005, Annals of Surgery.

[33]  P. Higgins,et al.  A quantifiable in vitro model to assess effects of PAI-1 gene targeting on epithelial cell motility. , 2003, Methods in molecular medicine.

[34]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[35]  F. Verrecchia,et al.  Transforming Growth Factor-β Signaling Through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation , 2002 .

[36]  P. Goldschmidt-Clermont,et al.  Upregulation of PAI-1 is mediated through TGF beta /SMAD pathway in transplant arteriopathy. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.